Berberis Vulgaris and Berberine: An Update Review

Phytotherapy Research

Volumn 30, Issue 11, 2016, Pages 1745-1764

  Imenshahidi, Mohsen ^a   Hosseinzadeh, Hossein ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

barberry; berberine; Berberis vulgaris; pharmacokinetic

Indexed keywords

BERBERINE; BLEOMYCIN; CISPLATIN; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; DIGOXIN; DOXORUBICIN; ISONIAZID; KETOCONAZOLE; METFORMIN; MULTIDRUG RESISTANCE PROTEIN; NEUROLEPTIC AGENT; SIMVASTATIN; PLANT EXTRACT;

ALLERGIC ENCEPHALOMYELITIS; ANALGESIC ACTIVITY; ANTIARRHYTHMIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTICONVULSANT ACTIVITY; ANTIDEPRESSANT ACTIVITY; ANTIDIARRHEAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIVIRAL ACTIVITY; ATHEROSCLEROSIS; BERBERIS VULGARIS; BRAIN INJURY; CARDIOTOXICITY; CARDIOVASCULAR RESPONSE; COCAINE DEPENDENCE; CONGESTIVE HEART FAILURE; CONSTIPATION; CONTRACEPTION; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIARRHEA; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG RESPONSE; DRUG STRUCTURE; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUNTINGTON CHOREA; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATORY BOWEL DISEASE; KIDNEY INJURY; KIDNEY ISCHEMIA; LIVER TOXICITY; LUNG TOXICITY; MINIMUM INHIBITORY CONCENTRATION; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OCCLUSIVE CEREBROVASCULAR DISEASE; OSTEOPOROSIS; OVARY POLYCYSTIC DISEASE; PARKINSON DISEASE; REVIEW; SPONTANEOUS ABORTION; STOMACH INJURY; TEMPORAL LOBE EPILEPSY; TREATMENT DURATION; TREATMENT OUTCOME; UROLITHIASIS; WEIGHT GAIN; BERBERIS; CHEMISTRY;

BERBERINE; BERBERIS; HUMANS; PLANT EXTRACTS;

EID: 84981742248     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5693     Document Type: Review

References (259)

1. Abdel Moneim AE. 2015. The neuroprotective effect of berberine in mercury-induced neurotoxicity in rats. Metab Brain Dis 30: 935–42.
2. Al-Quraishy S, Al-Khalifa MS, Dkhil MA. 2013. Role of berberine on schistosomiasis-inducted oxidative stress and damage in spleen of mice. Life Sci J 10: 135–139.
3. Alzamora R, O'Mahony F, Ko WH, et al. 2011. Berberine reduces cAMP-induced chloride secretion in T84 human colonic carcinoma cells through inhibition of basolateral KCNQ1 channels. Front Physiol 2: 33.
4. Amasheh M, Fromm A, Krug SM, et al. 2010. TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling. J Cell Sci 123: 4145–4155.
5. An Y, Sun Z, Zhang Y, et al. 2014. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clin Endocrinol 80: 425–431.
6. Bae J, Lee D, Kim YK, et al. 2013. Berberine protects 6-hydroxydopamine-induced human dopaminergic neuronal cell death through the induction of heme oxygenase-1. Mol Cells 35: 151–157.
7. Bashir S, Gilani AH, Siddiqui AA, et al. 2010. Berberis vulgaris root bark extract prevents hyperoxaluria induced urolithiasis in rats. Phytother Res 24: 1250–1255.
8. Benaissa F, Mohseni-Rad H, Rahimi-Moghaddam P, et al. 2009. Berberine reduces the hypoxic-ischemic insult in rat pup brain. Acta Physiol Hung 96: 213–220.
9. Bhutada P, Mundhada Y, Bansod K, et al. 2011. Berberine protects C57BL/6 J mice against ethanol withdrawal-induced hyperexcitability. Phytother Res 25: 302–307.
10. Boberek JM, Stach J, Good L. 2010. Genetic evidence for inhibition of bacterial division protein FtsZ by berberine. PLoS One 5: e13745.
11. Cameron J, Ranheim T, Kulseth MA, et al. 2008. Berberine decreases PCSK9 expression in HepG2 cells. Atherosclerosis 201: 266–273.
12. Campisi A, Acquaviva R, Mastrojeni S, et al. 2011. Effect of berberine and Berberis aetnensis C. Presl. alkaloid extract on glutamate-evoked tissue transglutaminase up-regulation in astroglial cell cultures. Phytother Res 25: 816–820.
13. Cao JX, Fu L, Sun DN. 2012. The effect of berberine on arrhythmia caused by stretch of myocardium, in vitro, of rats after myocardial ischemia. Chin J Emerg Med 21: 683–686.
14. Cao M, Wang P, Sun C, et al. 2013. Amelioration of IFN-gamma and TNF-alpha-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway. PLoS One 8: e61944.
15. Cecil CE. The effects of berberine on influenza a virus, influenza a virus-induced inflammation and the lipopolysaccharide-induced synthesis of prostaglandin E2. 3497233 Ph.D., North Carolina State University, Ann Arbor, 2011.
16. Cecil CE, Davis JM, Cech NB, et al. 2011. Inhibition of H1N1 influenza A virus growth and induction of inflammatory mediators by the isoquinoline alkaloid berberine and extracts of goldenseal (Hydrastis canadensis). Int Immunopharmacol 11: 1706–1714.
17. Chai YS, Yuan ZY, Lei F, et al. 2014. Inhibition of retinoblastoma mRNA degradation through Poly (A) involved in the neuroprotective effect of berberine against cerebral ischemia. PLoS ONE [Electronic Resource] 9: e90850.
18. Chandra DN, Prasanth GK, Singh N, et al. 2011. Identification of a novel and potent inhibitor of phospholipase A(2) in a medicinal plant: crystal structure at 1.93A and surface plasmon resonance analysis of phospholipase A(2) complexed with berberine. Biochim Biophys Acta 1814: 657–663.
19. Chang W, Wang H, Yin HF, et al. 2009. Effects of berberine on cholesterol metabolism and Insig-2 gene expression of hyperlipidemic rats. Chin Pharmacol Bull 25: 85–88.
20. Chang W, Zhang M, Li J, et al. 2012. Berberine attenuates ischemia-reperfusion injury via regulation of adenosine-5'-monophosphate kinase activity in both non-ischemic and ischemic areas of the rat heart. Cardiovasc Drugs & Ther 26: 467–478.
21. Chang X, Yan H, Fei J, et al. 2010. Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats. J Lipid Res 51: 2504–2515.
22. Chen CC, Hung TH, Lee CY, et al. 2014a. Berberine protects against neuronal damage via suppression of glia-mediated inflammation in traumatic brain injury. PLoS ONE [Electronic Resource] 9: e115694.
23. Chen FL, Yang ZH, Liu Y, et al. 2008. Berberine inhibits the expression of TNF[alpha], MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPAR[gamma] pathway. Endocrine 33: 331–337.
24. Chen H, Chen Y, Tang Y, et al. 2014b. Berberine attenuates spontaneous action potentials in sinoatrial node cells and the currents of human HCN4 channels expressed in Xenopus laevis oocytes. Mol Med Rep 10: 1576–1582.
25. Chen J-H, Huang S-M, Tan T-W, et al. 2012. Berberine induces heme oxygenase-1 up-regulation through phosphatidylinositol 3-kinase/AKT and NF-E2-related factor-2 signaling pathway in astrocytes. Int Immunopharmacol 12: 94–100.
26. Chen JL, Zhang YL, Dong Y, et al. 2013a. CYP450 enzyme inhibition of berberine in pooled human liver microsomes by cocktail probe drugs. Zhongguo Zhongyao Zazhi 38: 2009–2014.
27. Chen JL, Zhang YL, Dong Y, et al. 2013b. Enzyme reaction kinetics, metabolic enzyme phenotype, and metabolites of berberine. Chin Trad Herb Drugs 44: 3334–3340.
28. Chen W, Miao YQ, Fan DJ, et al. 2011. Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS PharmSciTech 12: 705–711.
29. Cheng C-C, C-Ma H, Liang K-W, et al. 2011. Role of JNK and c-Jun signaling pathway in regulation of human serum paraoxonase 1 gene transcription by berberine in human HepG2 cells. Eur J Pharmacol 650: 519–525.
30. Cheng F, Wang Y, Li J, et al. 2013. Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans. Int J Cardiol 167: 936–942.
31. Cheng WE, Ying Chang M, Wei JY, et al. 2015. Berberine reduces Toll-like receptor-mediated macrophage migration by suppression of Src enhancement. Eur J Pharmacol 757: 1–10.
32. Chi L, Peng L, Hu X, et al. 2014a. Berberine combined with atorvastatin downregulates LOX-1 expression through the ET-1 receptor in monocyte/macrophages. Int J Mol Med 34: 283–290.
33. Chi L, Peng L, Pan N, et al. 2014b. The anti-atherogenic effects of berberine on foam cell formation are mediated through the upregulation of sirtuin 1. Int J Mol Med 34: 1087–1093.
34. Chin LW, Cheng YW, Lin SS, et al. 2010. Anti-herpes simplex virus effects of berberine from Coptidis rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San. Arch Virol 155: 1933–1941.
35. Chitra P, Saiprasad G, Manikandan R, et al. 2013. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-kappaB dependant TGF-beta activation: a biphasic experimental study. Toxicol Lett 219: 178–193.
36. Chueh WH, Lin JY. 2011. Berberine, an isoquinoline alkaloid in herbal plants, protects pancreatic islets and serum lipids in nonobese diabetic mice. J Agric Food Chem 59: 8021–8027.
37. Cicero AF, Tartagni E. 2012. Antidiabetic properties of berberine: from cellular pharmacology to clinical effects. Hosp pract (1995) 40: 56–63.
38. Colombo D, Lunardon L, Bellia G. 2014. Cyclosporine and herbal supplement interactions. J Toxicol 2014: 145325.
39. Cui HM, Zhang QY, Wang JL, et al. 2014. In vitro studies of berberine metabolism and its effect of enzyme induction on HepG2 cells. J Ethnopharmacol 158Pt A: 388–396.
40. Cui HS, Matsumoto K, Murakami Y, et al. 2009. Berberine exerts neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures: involvement of B-cell lymphoma 2 phosphorylation suppression. Biol Pharm Bull 32: 79–85.
41. Derosa G, D'Angelo A, Bonaventura A, et al. 2013. Effects of berberine on lipid profile in subjects with low cardiovascular risk. Expert Opin Biol Ther 13: 475–482.
42. Derosa G, Maffioli P, Cicero AF. 2012. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opin Biol Ther 12: 1113–1124.
43. Dkhil MA. 2014. Role of berberine in ameliorating schistosoma mansoni-induced hepatic injury in mice. Biol Res 47: 8.
44. Dkhil MA, Al-Quraishy S. 2014. Evaluation of antiviral activity of berberine against herpes simplex viruses. J Pure and Appl Microbiol 8: 155–159.
45. Dkhil MA, Alazzouni AS, Al-Quraishy S, et al. 2015. Berberine protects against murine malaria-induced spleen tissue damage. Biomed Res (India) 26: 333–337.
46. Dkhil MA, Moneim AEA, Al-Quraishy S. 2014. Berberine protects against Schistosoma mansoni-induced oxidative damage in renal and testicular tissues of mice. Pak J Zool 46: 763–771.
47. Domitrovic R, Cvijanovic O, Pernjak-Pugel E, et al. 2013. Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and apoptosis. Food Chem Toxicol 62: 397–406.
48. Domitrovic R, Jakovac H, Blagojevic G. 2011. Hepatoprotective activity of berberine is mediated by inhibition of TNF-alpha, COX-2, and iNOS expression in CCl(4)-intoxicated mice. Toxicology 280: 33–43.
49. Dong H, Wang N, Zhao L, et al. 2012. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med 2012: art. no. 591654.
50. Dong S-F, Hong Y, Liu M, et al. 2011. Berberine attenuates cardiac dysfunction in hyperglycemic and hypercholesterolemic rats. Eur J Pharmacol 660: 368–374.
51. Du HZ, Lu XY, Du HW, et al. 2011. Absorption enhancement of sodium caprate on berberine in intestine of rats. J Jilin Univ Med Ed 37: 35–40.
52. Eidi A, Zarin Ghalam J, Rezazade SA, et al. 2011. Hepatoprotective effect of Berberis vulgaris L. extract on CCl4-induced toxicity in rats. Trauma Mon 16: 169–173.
53. Fallah Huseini H, Zaree Mahmoudabady A, Naghdi Badi H, et al. 2012. The protective effect of medicinal herbs extracts including Cynara scolymus L., Cichorium intybus L. Taraxacum officinal L. and Berberis vulgaris L. in single and in combination form in CCl4 induced rat liver toxicity. J Med Plants 11: 78–85.
54. Fallah Huseini H, Zareei Mahmpudabady A, Ziai SA, et al. 2010. The effects of Taraxacum officinale L. and Berberis vulgaris L. root extracts on carbon tetrachloride induced liver toxicity in rats. J Med Plants 9: 45–52.
55. Fan X, Wang J, Hou J, et al. 2015. Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK/mTOR signaling pathway. J Transl Med 13: 92.
56. Fatehi-Hassanabad Z, Jafarzadeh M, Tarhini A, et al. 2005. The antihypertensive and vasodilator effects of aqueous extract from Berberis vulgaris fruit on hypertensive rats. Phytother Res 19(222): –225.
57. Feng AW, Gao W, Zhou GR, et al. 2012. Berberine ameliorates COX-2 expression in rat small intestinal mucosa partially through PPARgamma pathway during acute endotoxemia. Int Immunopharmacol 12: 182–188.
58. Feng Y, Siu KY, Ye X, et al. 2010. Hepatoprotective effects of berberine on carbon tetrachloride-induced acute hepatotoxicity in rats. Chin Med 5: 33.
59. Fouladi RF. 2012. Aqueous extract of dried fruit of berberis vulgaris L. in acne vulgaris, a clinical trial. J Diet Suppl 9: 253–261.
60. Fratter, De Servi B. 2015. New oral delivery system to improve absorption of berberine: likely interaction of cationized chitosan with PG-P pump. Int J Drug Deliv (Jaipur) 5: 33–42.
61. Gholampour F, Karimifard F, Owji SM. 2015. Berberine improves liver injury following renal ischemia reperfusion in rats. Iran J Sci Technol Trans A Sci 39: 17–23.
62. Gholampour F, Owji SM, Mousavinia SS. 2014. Berberine ameliorates renal functional disorders and pulmonary tissue injury following renal ischemia/reperfusion in rats. Physiol Pharmacol 18: 82–91.
63. Godugu C, Patel AR, Doddapaneni R, et al. 2014. Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid. PLoS One 9: e89919.
64. Gu L, Li N, Gong J, et al. 2011. Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia. J Infec Dis 203: 1602–1612.
65. Gu L, Li N, Li Q, et al. 2009. The effect of berberine in vitro on tight junctions in human Caco-2 intestinal epithelial cells. Fitoterapia 80: 241–248.
66. Gu S, Cao B, Sun R, et al. 2015. A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine. Mol BioSyst 11: 463–474.
67. Guan S, Wang B, Li W, et al. 2010. Effects of berberine on expression of LOX-1 and SR-BI in human macrophage-derived foam cells induced by ox-LDL. Am J Chin Med 38: 1161–1169.
68. Gui SY, Wu L, Peng DY, et al. 2008. Preparation and evaluation of a microemulsion for oral delivery of berberine. Pharmazie 63: 516–519.
69. Guo Y, Chen Y, Tan ZR, et al. 2012. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol 68: 213–217.
70. Guo Y, Li F, Ma X, et al. 2011a. CYP2D plays a major role in berberine metabolism in liver of mice and humans. Xenobiotica 41: 996–1005.
71. Guo Y, Pope C, Cheng X, et al. 2011b. Dose-response of berberine on hepatic cytochromes P450 mRNA expression and activities in mice. J Ethnopharmacol 138: 111–118.
72. Guo Z, Sun H, Zhang H, et al. 2015. Anti-hypertensive and renoprotective effects of berberine in spontaneously hypertensive rats. Clin Exp Hypertens 37: 332–339.
73. Han L, Yang QH, Zhang YP, et al. 2015. Intervention of berberine on lipid deposition in liver cells of non-alcoholic fatty liver disease rats induced by high fat diet. Zhongguo Zhong Xi Yi Jie He Za Zhi 35: 314–319.
74. Hao G, Yu Y, Gu B, et al. 2015. Protective effects of berberine against doxorubicin-induced cardiotoxicity in rats by inhibiting metabolism of doxorubicin. Xenobiotica 45: 1024–1029.
75. Hao X, Yao A, Gong J, et al. 2012. Berberine ameliorates pro-inflammatory cytokine-induced endoplasmic reticulum stress in human intestinal epithelial cells in vitro. Inflammation 35: 841–849.
76. Holy EW, Akhmedov A, Luscher TF, et al. 2009. Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells. J Mol Cell Cardiol 46: 234–240.
77. Hong JS, Chu YK, Lee H, et al. 2012. Effects of berberine on hippocampal neuronal damage and matrix metalloproteinase-9 activity following transient global cerebral ischemia. J Neurosci Res 90: 489–497.
78. Hosseinzadeh H, Ramezani M, Shafaei H, et al. 2013. Anticonvulsant effect of Berberis integerrima L. Root Extracts in Mice JAMS J Acupunct Meridian Stud 6: 12–17.
79. Hu J, Chai Y, Wang Y, et al. 2012a. PI3K p55gamma promoter activity enhancement is involved in the anti-apoptotic effect of berberine against cerebral ischemia-reperfusion. Eur J Pharmacol 674: 132–142.
80. Hu JP, Nishishita K, Sakai E, et al. 2008. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways. Eur J Pharmacol 580: 70–79.
81. Hu PF, Chen WP, Tang JL, et al. 2011a. Protective effects of berberine in an experimental rat osteoarthritis model. Phytother Res 25: 878–885.
82. Hu Y Effects of berberine and its combinations on adipogenesis. 3484268 Ph.D., South Dakota State University, Ann Arbor, 2010.
83. Hu Y, Ehli EA, Kittelsrud J, et al. 2012b. Lipid-lowering effect of berberine in human subjects and rats. Phytomedicine 19: 861–867.
84. Hu Y, Kutscher E, Davies GE. 2010. Berberine inhibits SREBP-1-related clozapine and risperidone induced adipogenesis in 3 T3-L1 cells. Phytother Res 24: 1831–1838.
85. Hu Y, Young AJ, Ehli EA, et al. 2014. Metformin and berberine prevent olanzapine-induced weight gain in rats. PLoS One 9: e93310.
86. Hu Z, Jiao Q, Ding J, et al. 2011b. Berberine induces dendritic cell apoptosis and has therapeutic potential for rheumatoid arthritis. Arthritis Rheum 63: 949–959.
87. Huang Z, Meng S, Wang L, et al. 2012. Suppression of oxLDL-induced MMP-9 and EMMPRIN expression by berberine via inhibition of NF-kappaB activation in human THP-1 macrophages.[Erratum appears in Anat Rec (Hoboken). 2012 Sep;295(9):1405]. Anatomical Record (Hoboken, NJ: 2007) 295: 78–86.
88. Huang Z, Wang L, Meng S, et al. 2011. Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages. Int J Cardiol 146: 153–158.
89. Hwang KH, Ahn JY, Kim S, et al. 2009. Anti-obesity effect of berberine in mice fed a high fat diet. J Food Sci Nutr 14: 298–302.
90. Imenshahidi M, Qaredashi R, Hashemzaei M, et al. 2014. Inhibitory effect of Berberis vulgaris aqueous extract on acquisition and reinstatement effects of morphine in conditioned place preferences (CPP) in mice. Jundishapur J Nat Pharm Prod 9: e16145.
91. Jeong HW, Hsu KC, Lee JW, et al. 2009. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol Endocrinol Metab 296: E955–E964.
92. Jia X, Chen Y, Zidichouski J, et al. 2008. Co-administration of berberine and plant stanols synergistically reduces plasma cholesterol in rats. Atherosclerosis 201: 101–107.
93. Jia YJ, Xu RX, Sun J, et al. 2014. Enhanced circulating PCSK9 concentration by berberine through SREBP-2 pathway in high fat diet-fed rats. J Transl Med 12: 103.
94. Jiang W, Wei W, Gaertig MA, et al. 2015. Therapeutic effect of berberine on Huntington's disease transgenic mouse model. PLoS One 10: e0134142.
95. Jiang Y, Wu A, Zhu C, et al. 2013. The protective effect of berberine against neuronal damage by inhibiting matrix metalloproteinase-9 and laminin degradation in experimental autoimmune encephalomyelitis. Neurol Res 35: 360–368.
96. Jin L, He Q, Zhou QX, et al. 2010. Effect of berberine on lipid metabolism and expressions of low density lipoprotein receptor and scavenger receptor class-B type 1 genes in livers of hyperlipidemic rabbits. Chin J Biol 23: 1226–1229+1234.
97. Johnson M, Rafikhah N. 2014. Berberis vulgaris juice and acne vulgaris: a placebo-controlled study. Asian J Clin Nutr 6: 47–52.
98. Ju Y, Qiu W, Jiang X, et al. 2011. Effect of berberine on pharmacokinetics of digoxin after oral administration to rats. Zhongguo Zhongyao Zazhi 36: 918–921.
99. Kang S, Li Z, Yin Z, et al. 2015. The antibacterial mechanism of berberine against Actinobacillus pleuropneumoniae. Nat Prod Res 29: 2203–2206.
100. Kashkooli RI, Najafi SS, Sharif F, et al. 2015. The effect of berberis vulgaris extract on transaminase activities in non-alcoholic fatty liver disease. Hepat Mon 15: e25067.
101. Kheir MM, Wang Y, Hua L, et al. 2010. Acute toxicity of berberine and its correlation with the blood concentration in mice. Food Chem Toxicol 48: 1105–1110.
102. Khosrokhavar R, Ahmadiani A, Shamsa F. 2010. Antihistaminic and anticholinergic activity of methanolic extract of barberry fruit (Berberis vulgaris) in the guinea-pig ileum. J Med Plants 9: 99–105.
103. Kiasalari Z, Khalili M, Ahmadi P. 2011. Effect of alcoholic extract of berberis vulgaris fruit on acute and chronic inflammation in male rats. J Babol Univ Med Sci 13: 28–35.
104. Kim HJ. 2015. Berberine ameliorates allodynia induced by chronic constriction injury of the sciatic nerve in rats. J Med Food 18: 909–915.
105. Kim M, Cho KH, Shin MS, et al. 2014a. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease. Int J Mol Med 33: 870–878.
106. Kim M, Shin MS, Lee JM, et al. 2014b. Inhibitory effects of isoquinoline alkaloid berberine on ischemia-induced apoptosis via activation of phosphoinositide 3-kinase/protein kinase B signaling pathway. Int Neurourol J 18: 115–125.
107. Kim S, Chung JH. 2008a. Berberine prevents UV-induced MMP-1 and reduction of type I procollagen expression in human dermal fibroblasts. Phytomedicine 15: 749–753.
108. Kim S, Kim Y, Kim JE, et al. 2008b. Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes. Phytomedicine 15: 340–347.
109. Kim WS, Lee YS, Cha SH, et al. 2009. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. Am J Physiol Endocrinol Metab 296: E812–E819.
110. Kong W, Li Z, Xiao X, et al. 2010. Activity of berberine on Shigella dysenteriae investigated by microcalorimetry and multivariate analysis. J Therm Anal Calorim 102: 331–336.
111. Kong WJ, Wei J, Zuo ZY, et al. 2008. Combination of simvastatin with berberine improves the lipid-lowering efficacy. Metab Clin Exp 57: 1029–1037.
112. Kulkarni SK, Dhir A. 2008. On the mechanism of antidepressant-like action of berberine chloride. Eur J Pharmacol 589: 163–172.
113. Kwon IH, Choi HS, Shin KS, et al. 2009. Effects of berberine on 6-hydroxydopamine-induced Parkinsonism in rats. Korean J Pharmacog 40: 351–356.
114. Kwon M, Choi YA, Choi MK, et al. 2015. Organic cation transporter-mediated drug-drug interaction potential between berberine and metformin. Arch Pharm Res 38: 849–856.
115. Lao-Ong T, Chatuphonprasert W, Jarukamjorn K. 2013. Berberine disturbs the expression of sex-hormone regulated genes in β-naphthoflavone-induced mice. J Biol Sci 13: 271–276.
116. Lee B, Sur B, Yeom M, et al. 2012. Effect of berberine on depression- and anxiety-like behaviors and activation of the noradrenergic system induced by development of morphine dependence in rats. Korean J Physiol Pharmacol 16: 379–386.
117. Lee B, Yang CH, Hahm DH, et al. 2009. Inhibitory effects of Coptidis rhizoma and berberine on cocaine-induced sensitization. Evid Based Complement Alternat Med 6: 85–90.
118. Lee D, Bae J, Kim YK, et al. 2013. Inhibitory effects of berberine on lipopolysaccharide-induced inducible nitric oxide synthase and the high-mobility group box 1 release in macrophages. Biochem Biophys Res Commun 431: 506–511.
119. Lee HW, Suh JH, Kim H-N, et al. 2008. Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK. J Bone Miner Res 23: 1227–1237.
120. Lee T, Heo H, Kim KY. 2010a. Effect of berberine on cell survival in the developing rat brain damaged by MK-801. Exp Neurobiol 19: 140–145.
121. Lee TS, Pan CC, Peng CC, et al. 2010b. Anti-atherogenic effect of berberine on LXRalpha-ABCA1-dependent cholesterol efflux in macrophages. J Cell Biochem 111: 104–110.
122. Li DD, Xu Y, Zhang DZ, et al. 2013a. Fluconazole assists berberine to kill fluconazole-resistant Candida albicans. Antimicrob Agents Chemother 57: 6016–6027.
123. Li GH, Wang DL, Hu YD, et al. 2010a. Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy. Med Oncol 27: 919–925.
124. Li H, Dong B, Park SW, et al. 2009a. Hepatocyte nuclear factor 1alpha plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine. J Biol Chem 284: 28885–28895.
125. Li HM, Wang YY, Wang HD, et al. 2011a. Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms. Acta Pharmacol Sin 32: 1364–1372.
126. Li K, Yao W, Zheng X, et al. 2009b. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor a expression in macrophage. Cell Res 19: 1006–1017.
127. Li MH, Zhang YJ, Yu YH, et al. 2014a. Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy. Eur J Pharmacol 728: 67–76.
128. Li N, Gu L, Qu L, et al. 2010b. Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cells. Eur J Pharm Sci 40: 1–8.
129. Li Y, Chen X, Liu H, et al. 2009c. Effects of ginseng total saponins with berberine on plasma brain natriuretic peptide and Ca2+ concentration in experimental rats with chronic congestive heart failure. Zhongguo Zhongyao Zazhi 34: 324–327.
130. Li Y, Kuang H, Shen W, et al. 2013b. Letrozole, berberine, or their combination for anovulatory infertility in women with polycystic ovary syndrome: study design of a doubleblind randomised controlled trial. BMJ Open 3: e003934.
131. Li Y, Ma H, Zhang Y, et al. 2013c. Effect of berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial. Trials [Electronic Resource] 14: 226.
132. Li Y, Ren G, Wang YX, et al. 2011b. Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes. J Transl Med 9: 62.
133. Li Z, Jiang JD, Kong WJ. 2014b. Berberine up-regulates hepatic low-density lipoprotein receptor through Ras-independent but AMP-activated protein kinase-dependent Raf-1 activation. Biol Pharm Bull 37: 1766–1775.
134. Lin TY, Lin YW, Lu CW, et al. 2013. Berberine inhibits the release of glutamate in nerve terminals from rat cerebral cortex. PLoS One 8: e67215.
135. Linn YC, Lu J, Lim LC, et al. 2012. Berberine-induced haemolysis revisited: safety of Rhizoma coptidis and cortex phellodendri in chronic haematological diseases. Phytother Res 26: 682–686.
136. Liu BZ, Zhang J, Yang JQ, et al. 2008a. Protection and mechanism of berberine against chronic brain injury induced by aluminum-overload in rats. Chin Tradit Herb Drugs 39: 1351–1355.
137. Liu L, Liu J, Huang Z, et al. 2015a. Berberine improves endothelial function by inhibiting endoplasmic reticulum stress in the carotid arteries of spontaneously hypertensive rats. Biochem Biophys Res Commun 458: 796–801.
138. Liu SJ, Yin CX, Ding MC, et al. 2015b. Berberine inhibits tumor necrosis factoralphainduced expression of inflammatory molecules and activation of nuclear factorkappaB via the activation of AMPK in vascular endothelial cells. Mol Med Rep 12: 5580–5586.
139. Liu SJ, Yin CX, Ding MC, et al. 2014. Berberine suppresses in vitro migration of human aortic smooth muscle cells through the inhibitions of MMP-2/9, u-PA, AP-1, and NF-kB. BMB Rep 47: 388–392.
140. Liu Y, Hao H, Xie H, et al. 2009. Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats. J Pharm Sci 98: 4391–4401.
141. Liu Y, Lou SY, He YM. 2008b. Effects of berberine on cell proliferation, peroxisome proliferation activated receptor gamma, CAAT/enhancer binding protein mRNA and protein expression in 3 T3-L1 pre-adipocytes. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban 28: 1005–1009.
142. Liu YT, Hao HP, Xie HG, et al. 2010. Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metab Dispos 38: 1779–1784.
143. Lu DY, Tang CH, Chen YH, et al. 2010. Berberine suppresses neuroinflammatory responses through AMP-activated protein kinase activation in BV-2 microglia. J Cell Biochem 110: 697–705.
144. Luo Y, He Q, Jin L, et al. 2012. Effect of berberine on lipid metabolism and atherosclerosis of atherosclerotic rabbits. Chin J Biol 25: 193–196+199.
145. Luo Y, Jin L, He Q, et al. 2011. Effects of berberine on lipid metabolism and vitamin D receptor as well as insulin-induced gene 2 gene expression of rabbits. Chin Tradit Herb Drugs 42: 1566–1570.
146. Lv X, Yu X, Wang Y, et al. 2012. Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression. PLoS One 7: e47351.
147. Lv XY, Li J, Zhang M, et al. 2010. Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine. AAPS PharmSciTech 11: 372–382.
148. Ma J, Song B, Ruan H, et al. 2013a. Effect of berberine hydrochloride on the proliferation, apoptosis and cytokine secretion of splenocytes in mice. Xi bao yu fen zi mian yi xue za zhi = Chin j cell mol immunol 29: 802–804.
149. Ma JY, Feng R, Tan XS, et al. 2013b. Excretion of berberine and its metabolites in oral administration in rats. J Pharm Sci 102: 4181–4192.
150. Ma X, Jiang Y, Wu A, et al. 2010. Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice. PLoS One 5: e13489.
151. Mahmoud AM, Germoush MO, Soliman AS. 2014. Berberine attenuates isoniazid-induced hepatotoxicity by modulating peroxisome proliferator-activated receptory γ, oxidative stress and inflammation. Int J Pharmacol 10: 451–460.
152. Mahmoudi M, Zamani Taghizadeh Rabe S, Balali-Mood M, et al. 2016. Immunotoxicity induced in mice by subacute exposure to berberine. J Immunotoxicol 13: 255–262.
153. Mahmoudvand H, Ayatollahi Mousavi SA, Sepahvand A, et al. 2014a. Antifungal, antileishmanial, and cytotoxicity activities of various extracts of berberis vulgaris (berberidaceae) and its active principle berberine. ISRN Pharmacol 2014: 602436.
154. Mahmoudvand H, Saedi Dezaki E, Sharififar F, et al. 2014b. Protoscolecidal effect of Berberis vulgaris root extract and its main compound, berberine in cystic echinococcosis. Iran J Parasitol 9: 503–510.
155. Mahmoudvand H, Sharififar F, Rahmat MS, et al. 2014c. Evaluation of antileishmanial activity and cytotoxicity of the extracts of Berberis Vulgaris and Nigella sativa against Leishmania tropica. J Vector Borne Dis 51: 294–299.
156. Meng S, Wang LS, Huang ZQ, et al. 2012. Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention. Clin Exp Pharmacol Physiol 39: 406–411.
157. Mo C, Wang L, Zhang J, et al. 2014. The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice. Antioxid Redox Signal 20: 574–588.
158. Mojarad TB, Roghani M. 2014. The anticonvulsant and antioxidant effects of berberine in kainate-induced temporal lobe epilepsy in rats. Basic Clin Neurosci 5: 124–130.
159. Moon PD, Choi IH, Kim HM. 2011. Berberine inhibits the production of thymic stromal lymphopoietin by the blockade of caspase-1/NF-kappaB pathway in mast cells. Int Immunopharmacol 11: 1954–1959.
160. Nadjafi S, Ebrahimi SA, Rahbar-Roshandel N. 2014a. Effect of berberine on nitric oxide production during oxygen-glucose deprivation/reperfusion in OLN-93 oligodendrocytes. Pak J Biol Sci 17: 1185–1189.
161. Nadjafi S, Ebrahimi SA, Rahbar-Roshandel N. 2014b. Protective effects of berberine on oxygen-glucose deprivation/reperfusion on oligodendrocyte cell line (OLN- 93). Int J Prevent Med 5: 1153–1160.
162. Nam KN, Kim JH, Jung HJ, et al. 2010. Berberine inhibits inflammatory activation of rat brain microglia. Neural Regen Res 5: 1384–1390.
163. Niu L, Qiao W, Hu Z, et al. 2011. Berberine attenuates lipopolysaccharide-induced impairments of intestinal glutamine transport and glutaminase activity in rat. Fitoterapia 82: 323–330.
164. Pa B, Ya M, Ka B, et al. 2010. Inhibitory effect of berberine on the motivational effects of ethanol in mice. Prog Neuropsychopharmacol Biol Psychiatry 34: 1472–1479.
165. Pang B, Zhao LH, Zhou Q, et al. 2015. Application of berberine on treating type 2 diabetes mellitus. Int J Endocrinol 2015: 905749.
166. Parvu M, Parvu AE, Craciun C, et al. 2010. Changes in Botrytis cinerea conidia caused by Berberis vulgaris extract. Notulae Botanicae Horti Agrobotanici Cluj-Napoca 38: 15–20.
167. Patil S, Dash RP, Anandjiwala S, et al. 2013. Pharmacokinetic study of berberine from rasont and implication of lysergol for its bioavailability enhancement. J Liq Chromatogr Relat Technol 36: 336–348.
168. Peng L, Kang S, Yin Z, et al. 2015. Antibacterial activity and mechanism of berberine against Streptococcus agalactiae. Int J Clin Exp Pathol 8: 5217–5223.
169. Pham TP, Kwon J, Shin J. 2011. Berberine exerts anti-adipogenic activity through up-regulation of C/EBP inhibitors, CHOP and DEC2. Biochem Biophys Res Commun 413: 376–382.
170. Pisciotta L, Bellocchio A, Bertolini S. 2012. Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment. Lipids Health Dis 11: 123.
171. Qin X, Guo BT, Wan B, et al. 2010. Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberine. J Immunol 185: 1855–1863.
172. Qiu W, Jiang XH, Liu CX, et al. 2009. Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp. Phytother Res 23: 1553–1558.
173. Saha P, Bhattacharjee S, Sarkar A, et al. 2011. Berberine chloride mediates its anti-leishmanial activity via differential regulation of the mitogen activated protein kinase pathway in macrophages. PLoS One 6: e18467.
174. Saha P, Sen R, Hariharan C, et al. 2009. Berberine chloride causes a caspase-independent, apoptotic-like death in Leishmania donovani promastigotes. Free Radic Res 43: 1101–1110.
175. Salar F, Ziai SA, Nasri S, et al. 2010. Neuroprotective effect of aqueous extract of Berberis vulgaris L. in a model of Parkinson's disease in rat. J Med Plants 9: 24–33+216.
176. Salehabadi A, Karamian M, Farzad MH, et al. 2014. Effect of root bark extract of Berberis vulgaris L. on Leishmania major on BALB/c mice. Parasitol Res 113: 953–957.
177. Salehi S Effects of medicinal herbs on contraction rate of cultured cardiomyocyte. Possible mechanisms involved in the chronotropic effects of hawthorn and berberine in neonatal murine cardiomyocyte. 3385613 Ph.D., Oregon State University, Ann Arbor, 2009.
178. Sarna LK, Wu N, Hwang S-Y, et al. 2010. Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophages. Can J Physiol Pharmacol 88: 369–378.
179. Shang W, Liu J, Yu X, et al. 2010. Effects of berberine on serum levels of inflammatory factors and inflammatory signaling pathway in obese mice induced by high fat diet. Zhongguo Zhongyao Zazhi 35: 1474–1477.
180. Shi LY, Tian M, Chang W, et al. 2008. Effect of berberine on the expression of lipid metabolism-associated gene PPARα and CPTIA. Chin Pharmacol Bull 24: 1461–1464.
181. Shin HB, Choi MS, Yi CM, et al. 2015. Inhibition of respiratory syncytial virus replication and virus-induced p38 kinase activity by berberine. Int Immunopharmacol 27: 65–68.
182. Shin KS, Choi HS, Zhao TT, et al. 2013. Neurotoxic effects of berberine on long-term l-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Arch Pharm Res 36: 759–767.
183. Simoes Pires EN, Frozza RL, Hoppe JB, et al. 2014. Berberine was neuroprotective against an in vitro model of brain ischemia: survival and apoptosis pathways involved. Brain Rese 1557: 26–33.
184. Spatuzza C, Postiglione L, Covelli B, et al. 2014. Effects of berberine and red yeast on proinflammatory cytokines IL-6 and TNF-alpha in peripheral blood mononuclear cells (PBMCs) of human subjects. Front Pharmacol 5: 230.
185. Sugimoto T, Kato Y, Tsunoda Y. 2012. The effect of berberine treatment on the reversibility of the development of mouse zygotes and gametes, and on the fertilization and subsequent development. J Mamm Ova Res 29: 75–81.
186. Sun S, Wang K, Lei H, et al. 2014. Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine. Prog Neuropsychopharmacol Biol Psychiatry 49: 1–6.
187. Sun X, Zhang X, Hu H, et al. 2009. Berberine inhibits hepatic stellate cell proliferation and prevents experimental liver fibrosis. Biol Pharm Bull 32: 1533–1537.
188. Tan XS, Ma JY, Feng R, et al. 2013. Tissue distribution of berberine and its metabolites after oral administration in rats. PLoS One 8: e77969.
189. Tang QL, Zhong YF, Huang D, et al. 2014. Effect of berberine on visceral hypersensitivity in a rat model of irritable bowel syndrome. World Chin J Digestol 22: 4566–4572.
190. Teodoro JS, Duarte FV, Gomes AP, et al. 2013. Berberine reverts hepatic mitochondrial dysfunction in high-fat fed rats: a possible role for SirT3 activation. Mitochondrion 13: 637–646.
191. Tong N, Zhang J, Chen Y, et al. 2012. Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro. Oncol Lett 3: 1263–1267.
192. Tsunoda Y, Kato Y. 2011. Coptis rhizome and Phellodendron bark extracts and berberine inhibit the development of mouse embryos. J Mamm Ova Res 28: 40–46.
193. Vuddanda PR, Chakraborty S, Singh S. 2010. Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opin Investig Drugs 19: 1297–1307.
194. Wang H, Shi L, Yin H, et al. 2011a. Study on effect of berberine on modulating lipid and CPT I A gene expression. Zhongguo Zhongyao Zazhi 36: 2715–2718.
195. Wang J, Guo T, Peng QS, et al. 2015a. Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice. J Cell Mol Med 19: 2607–2616.
196. Wang J, He G, Li C, et al. 2009a. Effect of berberine on nuclear factor kappa b in the carotid artery atherosclerosis of rabbit. Med J Wuhan Univ 30: 156–158.
197. Wang J, Zhang S, Lü B. 2012. Protective effect and mechanism of berberine on intestinal damage induced by non-steroidal anti-inflammatory drugs. Chin J Gastroenterol 17: 466–470.
198. Wang J, Yang Z, Xu M, et al. 2009b. Berberine-induced decline in circulating CD31+/CD42- microparticles is associated with improvement of endothelial function in humans. Eur J Pharmacol 614: 77–83.
199. Wang LH, Yu CH, Fu Y, et al. 2011b. Berberine elicits anti-arrhythmic effects via IK1/Kir2.1 in the rat type 2 diabetic myocardial infarction model. Phytother Res 25: 33–37.
200. Wang T, Wang N, Ha S, et al. 2011c. Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine. Eur J Pharm Sci 44: 127–135.
201. Wang X-P, Lei F, Du F, et al. 2015b. Protection of gastrointestinal mucosa from acute heavy alcohol consumption: the effect of berberine and its correlation with TLR2, 4/IL1[beta]-TNF[alpha] signaling. PLoS One 10: e0134044.
202. Wang X, Qiu S, Yao X, et al. 2009c. Berberine inhibits Staphylococcus epidermidis adhesion and biofilm formation on the surface of titanium alloy. J Orthop Res 27: 1487–1492.
203. Wang X, Yao X, Zhu Z, et al. 2009d. Effect of berberine on Staphylococcus epidermidis biofilm formation. Int J Antimicrob Agents 34: 60–66.
204. Wang XH, Jiang SM, Sun QW. 2011d. Effects of berberine on human rheumatoid arthritis fibroblast-like synoviocytes. Exp Biol Med 236: 859–866.
205. Wang XX, Li W, Liu YC. 2010. Controlling effect of berberine on in vitro synthesis and metabolism of steroid hormones in insulin resistant ovary. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban 30: 161–166.
206. Wang Y, Yi X, Ghanam K, et al. 2014a. Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption. Metab Clin Exp 63: 1167–1177.
207. Wang Z, Chen Z, Yang S, et al. 2014b. Berberine ameliorates collagen-induced arthritis in rats associated with anti-inflammatory and anti-angiogenic effects. Inflammation 37: 1789–1798.
208. Wei P, Jiao L, Qin LP, et al. 2009. Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells. J Chin Integr Med 7: 342–348.
209. Wei W, Zhao H, Wang A, et al. 2012. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. Eur J Endocrinol 166: 99–105.
210. Wojtyczka RD, Dziedzic A, Kepa M, et al. 2014. Berberine enhances the antibacterial activity of selected antibiotics against coagulase-negative Staphylococcus strains in vitro. Molecules 19: 6583–6596.
211. Wu X, Li Q, Xin H, et al. 2005. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. Eur J Clin Pharmacol 61: 567–572.
212. Wu Y, Li JQ, Kim YJ, et al. 2011. In vivo and in vitro antiviral effects of berberine on influenza virus. Chin J Integr Med 17: 444–452.
213. Wu YH, Chuang SY, Hong WC, et al. 2012. Berberine reduces leukocyte adhesion to LPS-stimulated endothelial cells and VCAM-1 expression both in vivo and in vitro. Int J Immunopathol Pharmacol 25: 741–750.
214. Xiao CW, Ji QA, Wei Q, et al. 2015. Antifungal activity of berberine hydrochloride and palmatine hydrochloride against Microsporum canis-induced dermatitis in rabbits and underlying mechanism. BMC Complement Altern Med 15: 177.
215. Xiao M, Men LN, Xu MG, et al. 2014. Berberine protects endothelial progenitor cell from damage of TNF-alpha via the PI3K/AKT/eNOS signaling pathway. Eur J Pharmacol 743: 11–16.
216. Xiao X, Zhang Q, Feng K, et al. 2011. Berberine moderates glucose and lipid metabolism through multipathway mechanism. Evid Based Complement Alternat Med 2011: 924851.
217. Xie W, Gu D, Li J, et al. 2011. Effects and action mechanisms of berberine and rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6 J mice. PLoS One 6: e24520.
218. Xin HW, Wu XC, Li Q, et al. 2006. The effects of berberine on the pharmacokinetics of ciclosporin A in healthy volunteers. Methods Find Exp Clin Pharmacol 28: 25–29.
219. Xing L-J, Zhang L, Liu T, et al. 2011. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver. Eur J Pharmacol 668: 467–471.
220. Xu D, Yang W, Zhou C, et al. 2010. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats. Planta Med 76: 1809–1813.
221. Xu MG, Wang JM, Chen L, et al. 2008. Berberine-induced mobilization of circulating endothelial preogenitor cells improves human small artery elasticity. J Hum Hypertens 22: 389–393.
222. Xu MG, Wang JM, Chen L, et al. 2009a. Berberine-induced upregulation of circulating endothelial progenitor cells is related to nitric oxide production in healthy subjects. Cardiology 112: 279–286.
223. Xu Y, Wang Y, Yan L, et al. 2009b. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation. J Proteome Res 8: 5296–5304.
224. Yan HM, Xia MF, Wang Y, et al. 2015. Efficacy of berberine in patients with non-alcoholic fatty liver disease. PLoS One 10: e0134172.
225. Yan QN, Zhang S, Zhang ZQ. 2009. Study on the tissue distribution of berberine from Rhizoma Coptidis and compatibility with Rhizoma Coptidis and Cortex Cinnamomi in rats. J Chin Med Mat 32: 575–578.
226. Yang N, Wang J, Liu C, et al. 2014. Berberine and limonin suppress IgE production by human B cells and peripheral blood mononuclear cells from food-allergic patients. Ann Allergy Asthma Immunol 113: 556–564 e554.
227. Yang QH, Hu SP, Zhang YP, et al. 2011. Effect of berberine on expressions of uncoupling protein-2 mRNA and protein in hepatic tissue of non-alcoholic fatty liver disease in rats. Chin J Integrat Med 17: 205–211.
228. Yang Y, Qi J, Wang Q, et al. 2013. Berberine suppresses Th17 and dendritic cell responses. Invest Ophthalmol Vis Sci 54: 2516–2522.
229. Yashiki K, Kiso A, Zhou YY, et al. 2010. Abstracts: the effects of Coptis japonica root extract and its key component, berberine, on human subcutaneous adipocytes. Int J Cosmet Sci 32: 392–392.
230. Yin CM, Wang Q, Wang HL. 2009. Impact of emodin and berberine on the mRNA expression of leptin receptor in HepG2 cells treated with high concentrations of leptin. World Chin J Digestol 17: 1122–1125.
231. Yin WL, Luo HS, Han ZM. 2010. Berberine inhibits basolateral potassium current in rat colonic crypt cells. World Chin J Digestol 18: 3343–3346.
232. Yu F, Lin MS, Zhang WD. 2009. Inhibition of berberine on IKr, IKs and I Kl in thyroxine induced cardiomyopathic guinea pig ventricular myocytes. J Chin Pharm Univ 40: 244–249.
233. Yu L, Li F, Zhao G, et al. 2015. Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signaling. Apoptosis 20: 796–810.
234. Yu W, Sheng M, Xu R, et al. 2013. Berberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways. J Transl Med 11: 24.
235. Zeng XH, Zeng XJ, Li YY. 2003. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 92: 173–176.
236. Zhan L, Zhang D, Ao Y, et al. 2010. Protective effect of berberine on the nonalcoholic fatty liver induced by high-fat diet in rats. Med J Wuhan Univ 31: 65–67+91.
237. Zhang BJ, Xu D, Guo Y, et al. 2008a. Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors. Clin Exp Pharmacol Physiol 35: 303–309.
238. Zhang C, Shi YR, Liu XR, et al. 2015a. The anti-apoptotic role of berberine in preimplantation embryo in vitro development through regulation of miRNA-21. PLoS One 10: e0129527.
239. Zhang H, Wei J, Xue R, et al. 2010. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metab Clin Exp 59: 285–292.
240. Zhang J, Yang JQ, He BC, et al. 2009. Berberine and total base from rhizoma coptis chinensis attenuate brain injury in an aluminum-induced rat model of neurodegenerative disease. Saudi Med J 30: 760–766.
241. Zhang Q, Piao XL, Piao XS, et al. 2011. Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides.[Erratum appears in Food Chem Toxicol. 2011 May;49(5):1193]. Food Chem Toxicol 49: 61–69.
242. Zhang Q, Qian Z, Pan L, et al. 2012a. Hypoxia-inducible factor 1 mediates the anti-apoptosis of berberine in neurons during hypoxia/ischemia. Acta Physiol Hung 99: 311–323.
243. Zhang T, Yang S, Du J. 2014a. Protective effects of berberine on isoproterenol-induced acute myocardial ischemia in rats through regulating HMGB1-TLR4 axis. Evid Based Complement Alternat Med 2014: 849783.
244. Zhang XD, Ren HM, Liu L. 2008b. Effects of different dose berberine on hemodynamic parameters and [Ca2+]i of cardiac myocytes of diastolic heart failure rat model. Zhongguo Zhong Yao Za Zhi 33: 818–821.
245. Zhang Y, Chang X, Song X, et al. 2015b. Berberine reverses abnormal expression of L-type pyruvate kinase by DNA demethylation and histone acetylation in the livers of the non-alcoholic fatty disease rats. Int J Clin Exp Med 8: 7535–7543.
246. Zhang Y, Cui YL, Gao LN, et al. 2013. Effects of beta-cyclodextrin on the intestinal absorption of berberine hydrochloride, a P-glycoprotein substrate. Int J Biol Macromol 59: 363–371.
247. Zhang Y, Li X, Zhang Q, et al. 2014b. Berberine hydrochloride prevents postsurgery intestinal adhesion and inflammation in rats. J Pharmacol Exp Ther 349: 417–426.
248. Zhang Y, Li X, Zou D, et al. 2008c. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab 93: 2559–2565.
249. Zhang Y, Wang X, Sha S, et al. 2012b. Berberine increases the expression of NHE3 and AQP4 in sennosideA-induced diarrhoea model. Fitoterapia 83: 1014–1022.
250. Zhang YJ, Yang SH, Li MH, et al. 2014c. Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy. Clin Exp Pharmacol Physiol 41: 995–1002.
251. Zhang Z, Zhang H, Li B, et al. 2014d. Berberine activates thermogenesis in white and brown adipose tissue. Nat Commun 5: 5493.
252. Zhao H, Zhang T, Xia C, et al. 2014. Berberine ameliorates cartilage degeneration in interleukin-1beta-stimulated rat chondrocytes and in a rat model of osteoarthritis via Akt signalling. J Cell Mol Med 18: 283–292.
253. Zhao X, Zhang J, Tong N, et al. 2011. Berberine attenuates doxorubicin-induced cardiotoxicity in mice. J Int Med Res 39: 1720–1727.
254. Zhao Y, Yan D, Wang J, et al. 2010. Anti-fungal effect of berberine on Candida albicans by microcalorimetry with correspondence analysis. J Therm Anal Calorim 102: 49–55.
255. Zhou L, Wang X, Yang Y, et al. 2011. Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3 T3-L1 adipocytes. Biochim Biophys Acta 1812: 527–535.
256. Zhou XQ, Zeng XN, Kong H, et al. 2008. Neuroprotective effects of berberine on stroke models in vitro and in vivo. Neurosci Lett 447: 31–36.
257. Zhou Y, He P, Liu A, et al. 2012. Drug–drug interactions between ketoconazole and berberine in rats: pharmacokinetic effects benefit pharmacodynamic synergism. Phytother Res 26: 772–777.
258. Zhou Y, Liu SQ, Yu L, et al. 2015. Berberine prevents nitric oxide-induced rat chondrocyte apoptosis and cartilage degeneration in a rat osteoarthritis model via AMPK and p38 MAPK signaling. Apoptosis 20: 1187–1199.
259. Zimetti F, Adorni MP, Ronda N, et al. 2015. The natural compound berberine positively affects macrophage functions involved in atherogenesis. Nutr Metab Cardiovasc Dis 25: 195–201.